Eve Wellness provides FDA-approved automated breast ultrasound scanning (ABUS) to detect cancer in women with dense breast tissue, offering a radiation-free alternative to traditional mammography. The service enables early detection of potential risks in a comfortable, spa-like environment, with results delivered within 48 hours and no doctor referral required.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional mammography can miss a significant number of breast cancers, particularly in women with dense breast tissue, leading to delayed diagnoses and potentially poorer outcomes. Many women also seek a screening option that avoids radiation exposure.
Solution
Eve Wellness offers FDA-approved automated breast ultrasound scanning (ABUS) as a radiation-free alternative for detecting cancer, especially in women with dense breast tissue. The ABUS technology, combined with AI-assisted analysis, provides a detailed scan to identify breast lesions. The service aims to provide a comfortable and convenient experience, with scan results delivered within a few days. If an issue is detected, Eve Wellness can coordinate with the client's existing physician or help them find a new one.
Target Audience
The primary target audience includes women with dense breast tissue, women under 40 at average risk, those seeking radiation-free screening options, and individuals requiring secondary screening after a mammogram.
Features
- FDA-approved Automated Breast Ultrasound Scanning (ABUS) technology
- AI-assisted screening to identify potential lesions
- Radiation-free screening process
- Suitable for women with dense breast tissue, implants, or those who are pregnant
- Quick 15-20 minute scan time
- Results delivered within 48 hours
- Spa-like environment designed for comfort and relaxation